Department of Clinical Research, ICMR-National Institute for Research in Reproductive Health (NIRRH), JM Street, Parel, 400012, Mumbai, India.
Department of Clinical and Operational Research, ICMR-National Institute for Research in Reproductive Health (NIRRH), JM Street, Parel, 400012, Mumbai, India.
Indian J Tuberc. 2020 Jan;67(1):112-120. doi: 10.1016/j.ijtb.2020.01.002. Epub 2020 Jan 18.
Female genital tract tuberculosis (FGTB) is a chronic disease with varied presentation. The diagnosis of FGTB for early institution of treatment remains a clinical challenge. Its laboratory diagnosis is difficult because of paucibacillary nature of the condition and limitation of available diagnostic tests. In view of the intricate problems in diagnosis of FGTB, physicians tend to over treat with empirical anti-tuberculosis drugs. Apart from concerns of drug toxicity, this may be a contributing factor in the increasing incidence of multidrug-resistant TB reported in India. The main goal for advances in TB diagnostics is to reduce delay in diagnosis and treatment. In addition, there should be reduced complexity, improving robustness, and improving accuracy of the laboratory test for diagnosis of Female genital tuberculosis.
This narrative review is written with the following objectives. 1) To get a comprehensive overview as well as recent advances in diagnostic test used in the detection of FGTB. 2) To understand the limitations as well as advantages of these laboratory diagnostic test. 3) To provide clinical guidance regarding the detection in susceptible women.
The literature search was performed using electronic database of Pubmed, Medline, Embase and Google Scholar. Grey literature search was also done. Studies published in English were included. Following keywords were used for search - Tuberculosis, extra pulmonary tuberculosis, female genital tuberculosis, diagnosis of female genital tract tuberculosis. The personal knowledge and experience of authors in the field, helped in archiving the relevant articles.
Studies suggest that though culture is an invaluable contributor in the diagnosis of FGTB, molecular tests like PCR, LAMP, Xpert MTB/RIF and line probe assays have shown potential and are now being explored to strengthen the diagnostic algorithm of FGTB.
The use of algorithm approach with combination of both rapid culture and newer molecular techniques will facilitate the accurate and timely diagnosis of FGTB.
女性生殖道结核(FGTB)是一种具有多种表现的慢性疾病。为了进行早期治疗,对 FGTB 的诊断仍然是一个临床挑战。由于该病的菌量少,并且现有的诊断测试有限,因此其实验室诊断很困难。鉴于 FGTB 诊断的复杂问题,医生往往会凭经验用抗结核药物进行过度治疗。除了担心药物毒性外,这可能是导致印度报告的耐多药结核病发病率上升的一个因素。TB 诊断进展的主要目标是减少诊断和治疗的延迟。此外,实验室检测诊断女性生殖道结核的复杂性应降低,鲁棒性应提高,准确性也应提高。
本文旨在全面概述和介绍用于检测 FGTB 的诊断测试的最新进展。1)了解这些实验室诊断测试的局限性和优势。2)为检测易感女性提供临床指导。
使用 Pubmed、Medline、Embase 和 Google Scholar 电子数据库进行文献检索。还进行了灰色文献搜索。纳入发表在英语文献中的研究。使用以下关键词进行搜索:结核病、肺外结核病、女性生殖道结核、女性生殖道结核的诊断。作者在该领域的个人知识和经验有助于存档相关文章。
研究表明,虽然培养是诊断 FGTB 的宝贵贡献者,但聚合酶链反应(PCR)、环介导等温扩增(LAMP)、Xpert MTB/RIF 和线探针检测等分子检测方法已经显示出潜力,现在正在探索这些方法来加强 FGTB 的诊断算法。
采用快速培养和新型分子技术相结合的算法方法,将有助于准确、及时地诊断 FGTB。